Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 11, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Change in Accured Expenses (2020 - 2026)

Global Innovative Platforms' (GIPL) quarterly Change in Accured Expenses came in at -$5000.0 in Q1 2026, down 518.41% year-over-year from $1195.0 in Q1 2025, and down 66.67% quarter-over-quarter from -$3000.0 in Q4 2025.

Analysis

Global Innovative Platforms (GIPL) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Global Innovative Platforms has disclosed Change in Accured Expenses across 7 years of filings, most recently posting -$5000.0 for Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 518.41% year-over-year to -$5000.0; the TTM figure through Jun 2026 stood at -$31500.0 (down 173.94% YoY), while the FY2025 annual figure was -$30900.0, down 75.57% from the prior year.
  • Change in Accured Expenses came in at -$5000.0 for Q1 2026 at Global Innovative Platforms, down from -$3000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $50000.0 in Q3 2023 to a low of -$32400.0 in Q4 2024.
  • Average Change in Accured Expenses over 5 years is $1009.1, with a median of -$3000.0 recorded in 2025.
  • Year-over-year, Change in Accured Expenses surged 125.43% in 2022 and tumbled 518.41% in 2026.
  • Over 5 years, Change in Accured Expenses stood at -$5500.0 in 2022, then surged by 1009.09% to $50000.0 in 2023, then plunged by 164.8% to -$32400.0 in 2024, then surged by 90.74% to -$3000.0 in 2025, then plunged by 66.67% to -$5000.0 in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$5000.0 in Q1 2026, -$3000.0 in Q4 2025, and -$23500.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Idexx Laboratories 40.57 Bn 40.38 Bn 779.09 Mn -
2 Zoetis 30.57 Bn 28.90 Bn 1.05 Bn 142.00 Mn
3 Elanco Animal Health 11.47 Bn 10.94 Bn 798.00 Mn -
4 Phibro Animal Health 1.43 Bn 1.35 Bn 134.40 Mn 28.65 Mn
5 Immucell 87.38 Mn 78.52 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 64.40 Mn 57.30 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,000.00
Dec 31, 2025 -3,000.00
Sep 30, 2025 -23,500.00
Jun 30, 2025 23,805.00
Mar 31, 2025 1,195.00
Dec 31, 2024 -32,400.00
Sep 30, 2023 50,000.00
Jun 30, 2023 -10,053.00
Mar 31, 2023 10,053.00
Jun 30, 2022 -5,500.00
Mar 31, 2022 5,500.00
Sep 30, 2021 16,640.00
Jun 30, 2021 10,850.00
Mar 31, 2021 -21,629.00
Dec 31, 2020 15,000.00